Below is the preliminary program, which is subject to change by the start of the conference.
List of poster presentations is HERE.


Sunday, September 3


18:00 - 20:00
Participant registration, University of Belgrade Rectorate building (conference venue)
20:00 - 23:00
IAPC-10 Welcome party, Garden of the University of Belgrade Rectorate building (conference venue)
Wonder Strings Quartet (https://www.wonderstrings.com/en/) will play during the cocktail


Monday, September 4

18:30 - 17:00   Participant registration, University of Belgrade Rectorate building (conference venue)

19:00 - 19:45  Opening ceremony

Chairs: Tatjana Verbić and Zoran Mandić

10:00 - 10:40
pdf logo Christel Bergström, Uppsala University, Sweden
Virtual assessment to provide insights into drug-excipient-intestinal fluid interactions and support virtual formulation design
10:40 - 11:20
pdf logo Christos Reppas, University of Athens, Greece
In vitro evaluation of drug presence in the micellar phase of contents of upper small intestine: rationale, challenges, opportunities
11:20 - 11:50
pdf logo Gilles Goetz, Pfizer Inc, USA
Continuous Improvement in the molecular properties assessment world
11:50 - 12:20
  Analysis Coffee break + poster presentations

Chair: Godefridus Peters

12:20 - 13:00
pdf logo Gaia Colombo, University of Ferrara, Italy
Nanotechnology enabled innovation in inhalation drug delivery
13:00 - 13:40
pdf logo Miroslav Savić, University of Belgrade, Serbia
Neuropharmacokinetics: the secret life of – old and novel – psychopharmacological drugs
13:40 - 15:00
  Lunch break


Special session on Solubility of Multi-Component Solids (Salts and Cocrystals)
Session co-chairs: Kiyohiko Sugano and Alex Avdeef

15:30 - 16:10
pdf logo Alex Avdeef, in-ADME Research, New York, USA
Celebrating 40 years of the Ross electrode and 50 years of pHmax
16:10 - 16:50
pdf logo Kiyohiko Sugano, Ritsumeikan University, Japan
Salt disproportionation in bicarbonate buffer
16:50 - 17:30
pdf logo Abu Serajuddin, St. John’s University, New York, USA
Development of rapidly dissolving 3D-printed tablets for personalized medicine by applying acid-base supersolubilization (ABS) principle
17:30 - 18:00
  Coffee break + poster presentations
18:00 - 18:30
pdf logo Yan He, Sanofi, USA
Salt selection for development - solubility & bioperformance advantages from salts made by weaker acidic counterions explained by thermodynamic equilibria
18:30 - 19:00
pdf logo Tonglei Li, Purdue University, USA
Solubility prediction by deep learning of quantum information
19:00 - 19:30
pdf logo Sami Svanbäck, The Solubility Company Ltd. Helsinki, Finland
Micro-scale solubility measurement to guide early decision making
19:30 - 20:00
pdf logo Elisabet Fuguet, University of Barcelona, Spain
Insights in the solubility and dissolution rate determination of cocrystals
19:30 - 19:50
  Kader Poturcu, Suleyman Demirel University, Isparta, Turkey
Preparation and characterization of solid dispersion of mesalazine using anti-solvent precipitation technique
20:00 - 20:30
  Open discussions


Tuesday, September 5

Chair: Christel Bergström

19:00 - 19:40
pdf logo Tatjana Verbić, University of Belgrade, Serbia
Revealing the story of an orphan drug: clofazimine speciation and solubilization as a function of pH
19:40 - 10:20
pdf logo Annette Bauer Brandl, University of Southern Denmark, Denmark
Amorphous solid dispersions: true supersaturation measured in a time-resolved manner by microdialysis
10:20 - 11:00
pdf logo Godefridus Peters, Amsterdam University Medical Centers The Netherlands
Metabolism as a target for drug development
  Shimadzu Coffee break + poster presentations
Chair: Christos Reppas
11:30 - 12:10
pdf logo Kin Tam, University of Macau, China
Dichloroacetophenone derivatives as pyruvate dehydrogenase kinase inhibitor in non-small cell lung cancer models
12:10 - 12:40
pdf logo Andrej Perdih, National Institute of Chemistry, Ljubljana, Slovenia
Development of catalytic inhibitors of topoisomerase IIα as chemotherapeutic agents
12:40 - 13:10
pdf logo Sandra Cvijić, University of Belgrade, Serbia
Highlight on the benefits of PBPK modeling: A link between drug properties and it's in vivo performance
13:10 - 13:40
pdf logo Ines Nikolić, University of Belgrade, Serbia
Navigating Towards Improved Cytotoxicity Assessment in Nanomedicine Development: Shifting from Colorimetric to Fluorescence-Based Assays 
13:40 - 13:55
pdf logo Luka Mihajlović, Analysis d.o.o., Belgrade, Serbia
High-resolution mass spectrometry in drug discovery and design – trends and perspectivesd
13:55 - 14:10
pdf logo Stefan Jovanović, Shimadzu Coorporation, Serbia
Determination of active components in medicines and food on Shimadzu chromatographies
14:10 - 14:25
pdf logo Nebojša Jankov, PrimeVigilance Ltd, Belgrade, Serbia
Advancing drug safety: PrimeVigilance's comprehensive pharmacovigilance approach
14:25 - 14:40   Brief Exchange with Nenad M. Kostić
15:00 - 23:00
  Excursion to Viminacium (Roman City and Legionary Fort) with Conference dinner

Wednesday, September 6

Special Session on the ADME properties and toxicity prediction by HPLC
Chair: Klara Valko

19:00 - 19:40
pdf logo Laurence Philippe-Venec, PIC Analytics, USA
Chromatography to highlight compounds behavior in a membrane: a journey of interactions
19:40 - 10:20
pdf logo Giulia Caron, University of Turin, Italy
The love story of physchem data and oral bioavailable bRo5 drug candidates
10:20 - 10:50
pdf logo Krzesimir Ciura, Medical University of Gdańsk, Poland
Combining biomimetic chromatography and the Quantitative Structure-(Chromatographic) Retention Relationships approach using machine learning
10:50 - 11:20
  PrimeVigilance Coffee break + poster presentations
Chair: Krzesimir Ciura
11:20 - 12:00
pdf logo Klara Valko, Biomimetic chromatography, UK
Application of lipophilicity, protein and phospholipid binding measured by HPLC for prediction of ADME properties and toxicity of compounds
12:00 - 12:30
pdf logo Chrysanthos Stergiopoulos, University of Athens, Greece
Application of biomimetic chromatography for the prediction of acute aquatic toxicity of organic pollutants
12:30 - 13:00
pdf logo Giacomo Russo, Edinburgh University, Scotland
From delta logKwIAM to multidimensional biomimetic chromatography: a journey to shed light on the absorption potential of therapeutics. What will the future bring?
13:00 - 13:30
pdf logo Marti Roses, University of Barcelona, Spain
Ability of physicochemical systems to predict skin permeation of neutral compounds. A comparison study
13:30 - 14:00
  Open discussions about the future of the chromatographic techniques for the physicochemical characterization of compounds and prediction of their fate in vivo and in the environment
14:00 - 15:30
  Lunch break
Chair: Kin Tam
15:30 - 16:00
pdf logo Martin Kuentz, Univ. of Applied Sciences and Arts Northwestern Switzerland, Muttenz, Switzerland
Towards better understanding of drug interactions with mesoporous silica carriers by using inverse gas chromatography and molecular modelling
16:00 - 16:30
pdf logo Mire Zloh, UCL School of Pharmacy, UK
In silico approaches for understanding the role of intermolecular interactions in formulations and combination therapies: implications for ADME properties optimization
16:30 - 17:00
pdf logo Uko Maran, University of Tartu, Estonia
Octanol-water distribution coefficient (logD) as molecular descriptor to count environmental effect in QSAR models: comparison on experimental and predicted values for common reference drug substances for wide pH scale
17:00 - 17:30
pdf logo Robert Vianello, Rudjer Boskovic Institute, Zagreb, Croatia
With a little help from computer-aided drug design – new antitumor agents as tubulin polymerization inhibitors 
17:30 - 18:00 
  Coffee break + poster presentations
Chair: Mire Zloh
18:00 - 18:30
pdf logo Slavica Erić, University of Belgrade, Serbia
Elucidation of molecular mechanisms of activity of Echinacea spp. constituents for possible treatment of COVID 19 by computer-aided methods 
18:30 - 18:50
pdf logo Selma Zukić, University of Tartu, Estonia
Quantitative structure-activity relationship of pyrimidine and uracil derivatives for characterization and evaluation the potential of chemical compounds for cervical cancer
18:50 - 19:20
pdf logo Jelena Đuriš, University of Belgrade, Serbia
Bridging science & regulation: quality by design in patient-focused formulation development
19:20 - 19:50
pdf logo Milena Čukić Radenković, Empa Swiss Federal Laboratories for Materials Science and Technology, Switzerland
Improvement of Digital twin for transdermal fentanyl delivery based on anomalous diffusion
19:50 - 20:10   Closing ceremony
20:30 - 23:00   Farewell dinner (optional)